The company said that its trial data also show that patients with wild-type SIGMAR1 and COL24A1 genes may experience ...

The NHS will reconsider approving two Alzheimer’s “wonder drugs” after a successful appeal. The National Institute of Health ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Research from UC Santa Cruz indicates that the P3 peptide—an alternative cleavage product of the amyloid precursor ...

A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong ...

Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.

A decline in brain function interfering with daily living isn’t a normal part of aging. Dementia is on the rise, more than ...

The Alzheimer's Drug Discovery Foundation (ADDF) today announced that Isobel Coleman has been named Chief Executive Officer, ...

A new class of biomarker tests are able to diagnose some Alzheimer's cases. The next step would be predicting it: Here's ...